Variant report
Variant | nsv458318 |
---|---|
Chromosome Location | chr2:77564243-77603802 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529701682 | chr2:77585401-77585402 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs367608722 | chr2:77585405-77585406 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs144459616 | chr2:77585447-77585448 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563405130 | chr2:77585454-77585455 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs577707807 | chr2:77585466-77585467 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs544989507 | chr2:77585495-77585496 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563229810 | chr2:77585551-77585552 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs530531110 | chr2:77585559-77585560 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549266477 | chr2:77585581-77585582 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566714278 | chr2:77590600-77590601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569923481 | chr2:77590630-77590631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs143021698 | chr2:77590636-77590637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371738370 | chr2:77590638-77590639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187789056 | chr2:77590674-77590675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373751332 | chr2:77590675-77590676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527704295 | chr2:77590707-77590708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534724323 | chr2:77590739-77590740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555020900 | chr2:77590740-77590741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192567587 | chr2:77590782-77590783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs9309514 | chr2:77590797-77590798 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs557125829 | chr2:77590828-77590829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs142913218 | chr2:77590848-77590849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546069780 | chr2:77590976-77590977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs553420858 | chr2:77591036-77591037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183727520 | chr2:77591078-77591079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540689735 | chr2:77591090-77591091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560990035 | chr2:77591101-77591102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs529821813 | chr2:77591143-77591144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188465571 | chr2:77591151-77591152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563468992 | chr2:77591165-77591166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532376904 | chr2:77591190-77591191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs73941231 | chr2:77591205-77591206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565858237 | chr2:77591244-77591245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs368995055 | chr2:77591254-77591255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145245921 | chr2:77591255-77591256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs79242511 | chr2:77591257-77591258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528440363 | chr2:77591266-77591267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs202033745 | chr2:77591268-77591269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs200846341 | chr2:77591269-77591270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs67315330 | chr2:77591270-77591271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs58307818 | chr2:77591299-77591300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568158764 | chr2:77591300-77591301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs537147281 | chr2:77591301-77591302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557064325 | chr2:77591311-77591312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570698911 | chr2:77591325-77591326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs370378810 | chr2:77591326-77591327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs184581356 | chr2:77591355-77591356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189853365 | chr2:77591426-77591427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs138190844 | chr2:77591444-77591445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181533544 | chr2:77591469-77591470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Epilepsy | 22083797 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:77585400-77585600 | Bivalent Enhancer | Esophagus | oesophagus |
2 | chr2:77590600-77591200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr2:77590600-77591400 | Enhancers | Brain Anterior Caudate | brain |
4 | chr2:77591200-77591400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
5 | chr2:77591200-77591800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr2:77591400-77591800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr2:77593600-77593800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr2:77599000-77599200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |